Wayne Gombotz
Corporate Officer/Principal bei University of Washington
Profil
Wayne R.
Gombotz is an Assistant Professor at the University of Washington.
He previously worked as a Senior Director at Immunex Corp., a Staff Scientist at Bristol Myers Squibb Co. and Enzytech, a VP at Corixa Corp., a Vice President at Omeros Corp., and the Chief Development Officer at Immune Design Corp.
He is currently the Chief Technology Officer at Alpine Immune Sciences, Inc. Gombotz received his undergraduate degree from Colby College and his graduate and doctorate degrees from the University of Washington.
Aktive Positionen von Wayne Gombotz
| Unternehmen | Position | Beginn |
|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Wayne Gombotz
| Unternehmen | Position | Ende |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 21.08.2023 |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | 01.01.2018 |
| OMEROS CORPORATION | Corporate Officer/Principal | 30.11.2011 |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Corporate Officer/Principal | 01.03.2005 |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Corporate Officer/Principal | 01.09.2002 |
Ausbildung von Wayne Gombotz
| University of Washington | Doctorate Degree |
| Colby College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| OMEROS CORPORATION | Health Technology |
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Immunex Corp.
Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
Enzytech, Inc.
 Enzytech, Inc. Pharmaceuticals: MajorHealth Technology Enzytech, a biopharmaceutical company founded in 1987, developed mechanisms to deliver smaller doses of drugs specifically to their targets. | Health Technology |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
